| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |